Search

Your search keyword '"Rudolph, A. (Anja)"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Rudolph, A. (Anja)" Remove constraint Author: "Rudolph, A. (Anja)"
38 results on '"Rudolph, A. (Anja)"'

Search Results

1. Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation

2. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

3. Body mass index and breast cancer survival:a Mendelian randomization analysis

4. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

5. Genetic modifiers of CHEK2∗1100delC-associated breast cancer risk

6. Body mass index and breast cancer survival

7. Reproductive profiles and risk of breast cancer subtypes

8. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

9. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

10. Age-And tumor subtype-specific breast cancer risk estimates for CHEK2∗1100delC Carriers

11. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

12. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

13. Prognostic value of automated KI67 scoring in breast cancer: A centralised evaluation of 8088 patients from 10 study groups

14. High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium (BCAC)

15. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

16. Genetic predisposition to ductal carcinoma in situ of the breast

17. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

18. Fine-mapping of the 1p11.2 breast cancer susceptibility locus

19. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

20. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

21. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

22. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1

23. Prediction of breast cancer risk based on profiling with common genetic variants

24. Identification of novel genetic markers of breast cancer survival

25. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

26. Common germline polymorphisms associated with breast cancer-specific survival

27. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

28. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

29. Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers

30. Fine-scale mapping of the 4q24 locus identifies & pr two Independent loci associated with breast cancer risk

31. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

32. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

33. Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer

34. MicroRNA related polymorphisms and breast cancer risk

35. Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche

36. Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast

37. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

38. 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

Catalog

Books, media, physical & digital resources